By expenditures
| Name | Title | Type |
|---|---|---|
| Angelica Castillo | CHIEF FINANCIAL OFFICER | Auditee |
| Tami Preece | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 357417 | 2024 | 2025-05-29 | Blazek & Vetterling | $7.00M |
| 307040 | 2023 | 2024-05-23 | Blazek & Vetterling | $7.21M |
| 47820 | 2022 | 2023-05-21 | Blazek & Vetterling | $6.55M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 357417 | 2024 | 2025-05-29 | 1138201 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 1138200 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 1138199 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 1138198 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 1138197 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 1138196 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 1138195 | 2024-005 | Significant Deficiency | - | N |
| 357417 | 2024 | 2025-05-29 | 1138194 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 1138193 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 561759 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 561758 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 561757 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 561756 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 561755 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 561754 | 2024-003 | Material Weakness | Yes | B |
| 357417 | 2024 | 2025-05-29 | 561753 | 2024-005 | Significant Deficiency | - | N |
| 357417 | 2024 | 2025-05-29 | 561752 | 2024-004 | Significant Deficiency | - | BH |
| 357417 | 2024 | 2025-05-29 | 561751 | 2024-003 | Material Weakness | Yes | B |
| 307040 | 2023 | 2024-05-23 | 974811 | 2023-002 | Significant Deficiency | Yes | I |
| 307040 | 2023 | 2024-05-23 | 974810 | 2023-002 | Significant Deficiency | Yes | I |
| 307040 | 2023 | 2024-05-23 | 974809 | 2023-001 | Material Weakness | Yes | B |
| 307040 | 2023 | 2024-05-23 | 974808 | 2023-002 | Significant Deficiency | Yes | I |
| 307040 | 2023 | 2024-05-23 | 974807 | 2023-001 | Material Weakness | Yes | B |
| 307040 | 2023 | 2024-05-23 | 398369 | 2023-002 | Significant Deficiency | Yes | I |
| 307040 | 2023 | 2024-05-23 | 398368 | 2023-002 | Significant Deficiency | Yes | I |
| 307040 | 2023 | 2024-05-23 | 398367 | 2023-001 | Material Weakness | Yes | B |
| 307040 | 2023 | 2024-05-23 | 398366 | 2023-002 | Significant Deficiency | Yes | I |
| 307040 | 2023 | 2024-05-23 | 398365 | 2023-001 | Material Weakness | Yes | B |
| 47820 | 2022 | 2023-05-21 | 624150 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 624149 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 624148 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 624147 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 624146 | 2022-003 | Significant Deficiency | Yes | L |
| 47820 | 2022 | 2023-05-21 | 624145 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 624144 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 624143 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 624142 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 47708 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 47707 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 47706 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 47705 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 47704 | 2022-003 | Significant Deficiency | Yes | L |
| 47820 | 2022 | 2023-05-21 | 47703 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 47702 | 2022-001 | Material Weakness | - | B |
| 47820 | 2022 | 2023-05-21 | 47701 | 2022-002 | Significant Deficiency | - | I |
| 47820 | 2022 | 2023-05-21 | 47700 | 2022-001 | Material Weakness | - | B |